These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3291406)

  • 1. Systemic therapy of colorectal cancer.
    Hansen RM
    Wis Med J; 1988 May; 87(5):27-9. PubMed ID: 3291406
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
    Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
    Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of advanced and recurrent colorectal cancer].
    Tominaga T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2298-306. PubMed ID: 3488029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic cytostatic drug therapy in liver cancer.
    Glimelius B
    Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possible effect of administration methods on pharmacological action. Study of cytostatic therapy in advanced cancer].
    Larsson PA; Carlsson G; Gustavsson B; Glimelius B; Graf W
    Lakartidningen; 1995 Dec; 92(50):4793-6. PubMed ID: 8538293
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemotherapy for colon and rectal cancer.
    Fuchs CS; Mayer RJ
    Semin Oncol; 1995 Oct; 22(5):472-87. PubMed ID: 7570058
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
    Natoli C; Scognamiglio MT; Martino MT; Irtelli L; De Tursi M; Cianchetti E; Mascitelli E; Tinari N; Iacobelli S
    Anticancer Res; 2000; 20(2B):1253-6. PubMed ID: 10810430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.
    O'Connell MJ; Klaassen DJ; Everson LK; Cullinan S; Wieand HS
    NCI Monogr; 1987; (5):185-8. PubMed ID: 3501540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
    Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
    Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer.
    Cantrell JE; Hart RD; Taylor RF; Harvey JH
    Cancer Treat Rep; 1987 Jun; 71(6):615-8. PubMed ID: 3555789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
    Uemura N; Yamada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil and cytarabine--ineffective treatment in advanced colorectal carcinoma: a Southeastern Cancer Study Group Trial.
    Eisenstaedt RS; Neilan BA; Bartolucci A
    Cancer Treat Rep; 1987; 71(7-8):779-80. PubMed ID: 3300971
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant therapy of colorectal cancer.
    Kemeny N; Saltz L; Cohen A
    Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
    Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
    Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study.
    Ignoffo RJ; Friedman MA; Gribble M; Hannigan J; Reynolds R; Yu KP; Schiff S; Congdon JE
    Cancer Treat Rep; 1984; 68(7-8):983-8. PubMed ID: 6611204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgery and multidisciplinary treatment for colorectal cancer].
    Sakamoto J; Kato J; Yasue M
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):208-15. PubMed ID: 9474930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.
    Posner MR; Belliveau JF; Weitberg AB; Sabbath K; Wiemann MC; Cummings FJ; Calabresi P
    Cancer Treat Rep; 1987 Oct; 71(10):975-7. PubMed ID: 3308082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aggressive, sequential combination chemotherapy regimen in the treatment of metastatic colorectal carcinoma.
    Beck TM; Hart NE; Woodard DA; Smith CE
    Prog Clin Biol Res; 1986; 216():399-405. PubMed ID: 3088599
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
    Canobbio L; Nobile MT; Ardizzoni A; Tatarek R; Rosso R
    Cancer Treat Rep; 1986 Mar; 70(3):419-20. PubMed ID: 3955557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.